Title : Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.

Pub. Date : 2012 Mar

PMID : 22270945






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4 inhibitor. Rivaroxaban phosphoglycolate phosphatase Homo sapiens